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Aaron Conway, Zachary Conway, Kathleen Soalheira and Joanna SutherlandBACKGROUND The association between the quality of
evidence in systematic reviews and authors’ conclusions
regarding the effectiveness of interventions relevant to
anaesthesia has not been examined.
OBJECTIVE The objectives of this study were: to determine
the proportion of systematic reviews in which the authors
made a conclusive statement about the effect of an interven-
tion; to describe the quality of evidence derived from out-
comes in reviews that used the Grades of Recommendation,
Assessment, Development and Evaluation (GRADE)
working group system for grading the quality of evidence;
and to identify review characteristics associated with
conclusiveness.
DESIGN Cross-sectional analysis of Cochrane systematic
reviews from the Anaesthesia, Critical Care and Emergency
Review Group was undertaken.
DATA SOURCES The Cochrane webpage was used to
identify reviews for inclusion (http://.ace.cochrane.org/).
ELIGIBILITY CRITERIA New and updated versions of sys-
tematic reviews published up to 17 September 2015 were
eligible. Protocols for systematic reviews were excluded.Health and Biomedical Innovation, Kelvin Grove; Queensland Univ
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was used in 103 reviews (65%). Of these, high-level
evidence for the primary outcome was identified in 11
reviews (10%). The main reasons that quality of evidence
for the primary outcome was downgraded were risk of
bias (n¼44; 43%) and imprecision (n¼36; 35%). Authors
of 47% (n¼75) of the total number of reviews made
conclusive statements about the effects of interventions.
Independent predictors of conclusiveness in the subgroup
of reviews with GRADE assessments were quality of evi-
dence for the primary outcome (odds ratio 2.03; 95%
confidence interval: [1.18 to 3.52] and an increasing num-
ber of studies included in reviews (OR 1.05; 95% CI: [1.01
to 1.09]).
CONCLUSION It was common for conclusive statements
to be made about the effects of interventions despite
evidence for the primary outcome being rated less than
high quality. Improving methodological quality of trials
would have the greatest impact on improving the quality
of evidence.
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Clinicians rely on high-quality evidence to underpin valid
clinical decision-making. One of the widely used sources
of evidence is the Cochrane Database of Systematic
Reviews. Yet a recent study found that high-quality
evidence for medical and health-related interventions
was uncommon among all the Cochrane systematic
reviews published in 2014.1 Although this is an important
finding, it is unclear whether or not it was specific to asingle year or whether it was more generally applicable to
all Cochrane reviews, and especially to the evidence base
that has been evaluated by the Cochrane Anaesthesia,
Critical Care and Emergency Review Group. Further-
more, the influence of the quality of evidence on the
review authors’ ability to draw conclusions regarding
the effectiveness or lack of effectiveness of an inter-
vention has not been determined. The Grades ofersity Technology, Brisbane, Queensland (AC, ZC, KS) and Coffs Harbour Health
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uation (GRADE) tool can allow a systematic appraisal of
the quality of evidence for an outcome included in a
systematic review.2 GRADEwas adopted by Cochrane in
2008.3 The objectives of this study were: to determine
the proportion of reviews in which the authors were able
to make a conclusive statement about the effects of an
intervention; to describe the quality of evidence derived
from primary and secondary outcomes in reviews that
used the GRADE system for grading the quality of
evidence; and to identify review characteristics associat-
ed with conclusiveness.
Methods
Design
A cross-sectional analysis of the quality of evidence in
Cochrane systematic reviews from the Anaesthesia, Crit-
ical Care and Emergency Review Group was undertaken.
Inclusion criteria
New and updated versions of systematic reviews pub-
lished by the Cochrane Anaesthesia, Critical Care and
Emergency ReviewGroup published up to 17 September
2015 were eligible for inclusion in this analysis. Protocols
for systematic reviews were excluded.
Outcome definitions
For a review to be conclusive, the authors of the
Cochrane systematic review had to have made a defini-
tive statement about the effects of an intervention. As
such, this assessment of conclusiveness should be con-
sidered subjective; it was based on the author’s conclu-
sions section of the abstract and the implications for
practice sections of the main text of the review. An
example of a statement that was interpreted to be ‘con-
clusive’ was ‘bispectral index-guided anaesthesia can
reduce the risk of intraoperative awareness in surgical
patients at high risk for awareness in comparison to using
clinical signs as a guide for anaesthetic depth’.4
Data sources
The Cochrane Anaesthesia, Critical Care and Emergency
Review Group webpage was used to identify reviews for
inclusion (http://ace.cochrane.org/). The full version of all
identified reviews was then accessed for data collection.
Data collection
Data from reviews were extracted onto a standardised
form by Z.C. after A.C. first subjected it to a pilot test of
10 reviews. Information on the following aspects of the
included reviews was extracted:
Characteristics of the review: year of publication, status of
review (new or update), number of studies included, type
of studies included [coded as only randomised controlled
trial (RCT) or other], number of participants included,
discipline area (anaesthesia, critical care, emergency),type of interventions evaluated (coded as pharmacologi-
cal, nonpharmacological or medical device).
Quality of evidence: number of outcomes assigned a
GRADE rating, GRADE rating of the first listed primary
outcome, highest GRADE rating for secondary out-
comes, number of outcomes for each GRADE category
and reasons for downgrading primary outcome (risk of
bias, imprecision, inconsistency, publication bias, indi-
rectness).
Two authors (Z.C. and K.S.) accessed the full version of
the reviews and independently evaluated those included
for conclusiveness according to the predefined criteria.
Disagreements were resolved by discussion with a third
author (A.C.).
Statistical analysis
Descriptive statistics were used to calculate frequency
and percentages for dichotomous data. Median and inter-
quartile ranges (IQRs) were calculated for continuous
data. Backward stepwise logistic regression was used for
multivariate analyses. The final model was determined
using a removal probability of 0.10. As this study was
concerned with the interface between the authors’ deci-
sion-making regarding conclusiveness about the evi-
dence for an effect of interventions and the quality of
evidence available to inform those decisions, we included
only the following variables in the multivariate analysis:
the number of studies included in each review; the total
number of participants included in each review; the
number of outcomes assigned a GRADE rating; the
quality of evidence for the primary outcome and the
highest quality of evidence for a secondary outcome.
Reviews that did not assign a GRADE rating were not
included in the multivariate analysis. The review cate-
gory (anaesthesia, critical care, emergency) or interven-
tion category (pharmacological, nonpharmacological,
medical device) were not included. Quality of evidence
was included in the analyses as a numerical variable.
Accordingly, this assumes that the distances between
the quality levels were equal and relevant (i.e. a one unit
change from very low quality to low quality is equal to a
change from moderate to high quality). Very low-quality
evidence was coded as 1, low-quality evidence coded as 2,
moderate-quality evidence coded as 3 and high-quality
evidence coded as 4. The Hosmer–Lemeshow goodness
of fit test was used to assess model fit. A P value of 0.05
was the threshold accepted for statistical significance.
Results
A total of 159 reviews were included. Table 1 presents
the review characteristics. There were 83 reviews (52%)
categorised as being centred on anaesthesia. About 64
reviews (40%) were categorised as critical care. A smaller
number of reviews were for emergency medicine (n¼ 12;
8%). Pharmacological therapy was the most common type
of intervention (n¼ 98; 62%). The median number ofEur J Anaesthesiol 2017; 34:808–813
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Table 1 Review characteristics categorised by conclusiveness
Characteristic
All nU159
n (%) or
median
(IQR)
Conclusive
nU75
n (%) or
median
(IQR)
Inconclusive
nU84
n (%) or
median
(IQR)
Specialty area
Anaesthesia 83 (52) 45 (60) 38 (45)
Critical care 65 (41) 27 (36) 38 (45)
Emergency 11 (7) 3 (4) 8 (10)
Intervention category
Pharmacological therapy 98 (62) 49 (66) 49 (58)
Nonpharmacological 15 (9) 7 (9) 8 (10)
Medical device 46 (29) 19 (25) 27 (32)
Number of included studies 10 (4, 21) 14.5 (6, 28) 6 (2, 15)
Only randomised trials included 135 (85) 66 (88) 69 (85)
Total number of included
participants
1046
(402, 2267)
1368
(614, 2833)
759
(261, 1738)studies included in the reviews was 10 (IQR 4 to 21).
Only RCTs were included in the majority of reviews
(n¼ 135; 85%). One of the reviews was an overview of
Cochrane reviews and one was a diagnostic test accuracy
review. The median number of participants in the
reviews was 1046 (IQR 402 to 2267).
Quality of evidence
A total of 103 reviews (65%) used the GRADE system to
evaluate the quality of evidence. A summary of the
quality of evidence ratings for primary and secondary
outcomes is provided in Tables 1–3. Out of these
reviews, only a small number identified high-level evi-
dence for the first listed primary outcome (n¼ 11; 10%).
There was moderate-quality evidence for the first listed
primary outcomes of 35 reviews (34%), low-quality evi-
dence in 42 reviews (41%) and very low-quality evidence
in 15 reviews (15%). In total, 16 reviews had a secondaryTable 2 Quality of evidence for primary outcome categorised by conc
Characteristic All nU10
(%) or media
Number of outcomes assigned a GRADE rating 6 (4, 7
High-quality evidence for primary outcome 11 (11)
Moderate-quality evidence for primary outcome 35 (34)
Low-quality evidence for primary outcome 42 (40)
Very low-quality evidence for primary outcome 15 (15)
Primary outcome downgraded because of risk of bias 44 (43)
Primary outcome downgraded because of imprecision 36 (35)
Primary outcome downgraded because of inconsistency 18 (18)
Primary outcome downgraded because of publication bias 18 (18)
Primary outcome downgraded because of indirectness 7 (7)
GRADE, Grades of Recommendation, Assessment, Development and Evaluation.
Table 3 Quality of evidence for secondary outcomes categorised by c
Characteristic All nU89 n (%)
High-quality evidence for any secondary outcome 16 (18)
Moderate-quality evidence for any secondary outcome 27 (30)
Low-quality evidence for any secondary outcome 33 (37)
Very low-quality evidence for any secondary outcome 13 (15)
Eur J Anaesthesiol 2017; 34:808–813outcome with high-level evidence (18%). A larger pro-
portion had moderate (n¼ 27; 30%) and low (n¼ 33; 37%)
level evidence. Secondary outcomes were graded as very
low for 13 reviews (15%). A summary of GRADE ratings
for primary and secondary outcomes across specialty areas
and intervention categories is presented in Table 4. The
level of evidence for the first listed primary outcome was
downgraded because of risk of bias in 44 reviews (43%),
for imprecision in 36 reviews (35%), inconsistency in 18
reviews (18%), publication bias in 18 reviews (18%) and
indirectness in seven reviews (7%). A summary of the
reasons for downgrading GRADE ratings across specialty
areas and intervention categories is presented in Table 5.
Conclusiveness of the evidence
In 75 reviews (47%), we judged that the review authors
made a conclusive statement about the effects of an
intervention. On univariate analysis, a higher number
of studies were included in conclusive reviews (median
14.5 in conclusive and six in inconclusive reviews;
P< 0.001) as was the total number of participants (medi-
an 1368 in conclusive and 759 in inconclusive reviews;
P¼ 0.002). The quality of evidence for the primary (16%
conclusive and 6% inconclusive) and secondary outcomes
(24% conclusive and 10% inconclusive) was graded as
higher in conclusive reviews. Results of the multivariate
analysis are presented in Table 6. Quality of evidence for
the primary outcome was an independent predictor of
conclusiveness (OR 2.03; 95% CI: [1.18 to 3.52]). Authors
of reviews were 5%more likely to havemade a conclusive
statement about the effects of an intervention with each
additional included study (OR 1.05; 95% CI: [1.01 to
1.09]). Variables not significantly associated with conclu-
siveness in the multivariate model were the number of
outcomes assigned a GRADE rating, the quality oflusiveness
3 n
n (IQR)
Conclusive nU51
n (%) or median (IQR)
Inconclusive nU52
n (%) or median (IQR)
) 6 (4, 7) 5 (3, 6)
8 (16) 3 (6)
23 (45) 12 (23)
17 (33) 25 (48)
3 (6) 12 (23)
18 (36) 26 (50)
11 (22) 25 (48)
8 (16) 10 (19)
11 (22) 7 (13)
2 (4) 5 (10)
onclusiveness
Conclusive nU46 n (%) Inconclusive nU43 n (%)
11 (24) 5 (11)
19 (41) 8 (19)
14 (31) 19 (44)
2 (4) 11 (26)
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Table 4 Summary of Grades of Recommendation, Assessment, Development and Evaluation ratings (nU103)
Specialty area Intervention category
Anaesthesia Critical care Emergency Medication Medical device Nonpharmacological
Quality of evidence nU55 nU42 nU6 nU62 nU30 nU11
First listed primary outcome High 5 (9) 4 (9) 2 (33) 7 (11) 3 (10) 1 (9)
Moderate 18 (33) 16 (38) 1 (17) 23 (37) 11 (36) 2 (20)
Low 26 (47) 15 (36) 1 (17) 22 (36) 13 (43) 6 (54)
Very low 6 (11) 7 (17) 2 (33) 10 (16) 3 (10) 2 (18)
Secondary outcomea n¼46 n¼39 n¼4 n¼51 n¼29 n¼9
High 6 (13) 10 (26) 0 (0) 7 (14) 8 (27) 1 (11)
Moderate 14 (30) 12 (30) 1 (25) 20 (39) 6 (21) 1 (11)
Low 22 (48) 10 (26) 1 (25) 13 (25) 13 (45) 7 (78)
Very low 4 (9) 7 (18) 2 (50) 11 (22) 2 (7) 0 (0)
Data are given as n (%). a Denominator is different from primary outcome because not all reviews that used Grades of Recommendation, Assessment, Development and
Evaluation included a secondary outcome.
Table 5 Reasons for downgrading Grades of Recommendation, Assessment, Development and Evaluation ratings for primary outcomes
Specialty area Intervention category
Anaesthesia Critical care Emergency Medication Medical device Nonpharmacological
Reasons nU50 nU38 nU6 nU55 nU27 nU10
Risk of bias 23 (46) 18 (47) 3 (50) 23 (42) 14 (52) 7 (70)
Imprecision 16 (32) 17 (45) 3 (50) 17 (31) 14 (52) 5 (50)
Inconsistency 7 (14) 10 (26) 1 (17) 8 (15) 7 (26) 3 (30)
Publication bias 6 (12) 10 (26) 2 (33) 10 (18) 7 (26) 1 (10)
Indirectness 3 (6) 2 (5) 2 (33) 6 (11) 0 (0) 1 (10)
Data are given as n (%). Columns totals are the number of reviews that used Grades of Recommendation, Assessment, Development and Evaluation and downgraded the
quality of evidence. Frequencies and percentages in each column are not cumulative because a primary outcome could have been downgraded for more than one reason.
Table 6 Independent predictors of conclusiveness for reviews that used Grades of Recommendation, Assessment, Development and
Evaluation
95% CI for OR
Variables OR Significance Lower Upper
Quality of evidence for the primary outcome 2.03 0.011 1.18 3.52
Total number of studies in the review 1.05 0.005 1.01 1.09
Number of outcomes assigned a GRADE rating 1.21 0.062 0.99 1.47
Variables removed from model: secondary outcome quality of evidence and total number of participants. CI, confidence interval; GRADE, Grades of Recommendation,
Assessment, Development and Evaluation; OR, odds ratio.evidence for secondary outcomes and total number
of participants.Discussion
We found that only one in 10 Cochrane reviews in
Anaesthesia, Critical Care and Emergency Medicine that
used the GRADE approach graded the quality evidence
for a primary outcome as high. As such, clinicians do not
have firm evidence to support the effectiveness of a large
number of interventions across these medical specialty
areas. An even lower proportion of Cochrane reviews with
high-quality evidence was identified in the field of or-
thodontics (2%).5 Findings from previous analyses of
Cochrane reviews in other medical specialties have var-
ied, with some reporting a large proportion of conclusive
reviews,6,7 whereas others were more likely to be incon-
clusive.8,9 The total number of studies and total number
of included participants were associated with review
conclusiveness.6–9 It is important to note that theseprevious studies of the conclusiveness of Cochrane
reviews did not evaluate reviewers’ judgements about
the quality of evidence. Examinations of non-Cochrane
reviews have concentrated on the methodological quality
of the reviews instead of an analysis of the conclusions.10
We were unable to locate a study that centred on the
conclusiveness of non-Cochrane reviews in the literature.
As would reasonably be expected, the likelihood that a
review was conclusive increased with the number of
studies it included and its quality of evidence for the
primary outcome. However, the small proportion of
reviews in which there was high-quality evidence for
the primary outcome (10%) and secondary outcomes
(16%) is noteworthy and consistent with findings of a
broader review of evidence in Cochrane reviews.1 It
indicates that many reviewers have drawn conclusions
about the effects of interventions based on uncertain
effect estimates that may change with results from further
research.2 It is possible that this could have negativeEur J Anaesthesiol 2017; 34:808–813
812 Conway et al.implications for clinical practice if further research indi-
cates an intervention is not effective or if it is found to be
harmful. Improving the quality of the design and report-
ing of RCTs in Anaesthesia, Critical Care andEmergency
Medicine should be considered a high priority in addres-
sing this problem; we have identified that the most
common reason for downgrading the quality of evidence
was risk of bias.
One benefit of a systematic review, which arises from
accumulation of data from multiple studies, is increased
statistical power to detect the effect of an intervention.
The available evidence was still insufficient for a large
number of primary outcomes examined by the Cochrane
reviews included in our analysis. In line with previous
studies of Cochrane reviews,11 we identified that the
quality of evidence for a large number of primary out-
comes was downgraded because of imprecision. We did
not investigate reasons for imprecision in our analysis. It
may be that, for pragmatic reasons, surrogate outcomes
were used for sample size estimation of RCTs for a specific
intervention but it was then appropriately decided that
clinical outcomes should be examined as the primary out-
come of a Cochrane systematic review. For this reason,
althoughwe found that a large number of primary outcomes
were downgraded because of imprecision, this should not
necessarily be seen as a limitation.
Downgrading because of risk of publication bias was not
common (18%) in the sample of Cochrane reviews that
we analysed. This was consistent with results of a recent
evaluation of publication bias reported in systematic
reviews and meta-analyses published in anaesthesiology
journals (16%; n¼ 34).12 Of note, these authors identified
that there was a greater likelihood of publication bias
among reviews not performing these evaluations. We did
not extract data about how publication bias was assessed
in each review. However, assessment of reporting bias is a
core component of Cochrane review methods and guid-
ance on how to detect publication bias specifically is
addressed in the handbook.3 Therefore, it could be
assumed that the quality of evidence for primary out-
comes that required downgrading for publication bias
was accurate.
Downgrading the quality of evidence for indirectness and
inconsistency was not as common in the sample of
Cochrane reviews that we analysed. This may indicate
that Cochrane reviews in these fields were highly tar-
geted at interventions for particular patient groups.
A finding worthy of further discussion is that conclusive
statements about the effects of interventions were made
in similar proportions of reviews that did (n¼ 51; 49%)
and did not (n¼ 52; 51%) use the GRADE approach. One
interpretation is that the GRADE approach may not play
a relevant role when reviewers are crafting their state-
ments about the effects of interventions. Conversely, this
could also be interpreted that further efforts are requiredEur J Anaesthesiol 2017; 34:808–813to assist review authors to apply GRADE assessments in
their interpretations about the evidence. However, it
should be noted that an evaluation of the impact of using
GRADE or not on review authors’ interpretation as to
whether an intervention may be of value for clinical
practice was not a specific aim of this study. A comparison
of Cochrane reviews that use GRADE with non-
Cochrane reviews that may or may not have used
GRADE at the same time period on the same topic
would be a more appropriate way to investigate the
potential benefits of using GRADE in drawing conclu-
sions about the effects of interventions.
Our finding that it was common for review authors to
make a conclusive statement about the effects of an
intervention when there was less than high-quality evi-
dence for the primary outcome suggests that the conclu-
siveness of a systematic review may not be reducible to
the quality of evidence for a single primary outcome.
This conflicts with general recommendations in the
Cochrane Handbook that conclusions about the effects
of interventions should largely be based on the primary
outcomes.13 The rationale behind basing conclusions
about the effects of interventions mainly on results of
primary outcomes in a systematic review is not as clear as
it is for RCTs. In a RCT, the primary outcome is the
outcome used to calculate the sample size.14 It is not
typical for a sample size calculation to be conducted for
the primary outcome of a systematic review.
A further relevant issue is the potential for subjectivity in
GRADE assessments. It is recognised that a potential
drawback of GRADE assessments is its complexity and
consequent potential for inconsistency in judgements
between review authors. There have been inconsistent
findings in studies that examined the agreement in
GRADE assessment between multiple reviewers.15,16
The impact of this subjectivity in GRADE assessments
on review authors’ interpretations of the evidence in the
sample of reviews we examined is unknown. Preliminary
results of research into the effectiveness of automating
quality assessment for systematic reviews are promising
and could represent a potential solution to this problem.17
Limitations
We did not register a protocol for this cross-sectional
study of Cochrane reviews. It is also important to consider
the implications of the subjectivity of our assessment of
the conclusiveness of the reviews included in our study.
Although two authors evaluated all reviews for conclu-
siveness and a third author resolved initial discrepancies,
it is possible that other readers of the included reviews
may interpret the review authors’ statements differently.
We included GRADE ratings in the multivariate analysis
as a numerical variable. There is no supporting evidence
available to confirm that the difference in quality of
evidence for an outcome is equal between each quality
level. As variables related to GRADE assessment were
Quality of evidence in Cochrane systematic reviews 813included in the multivariate analysis of predictors of
review conclusiveness, all reviews without GRADE
assessments were excluded. Although this must be con-
sidered a limitation, we considered that the results are
informative for the contemporary context, because all
Cochrane reviews must now include a GRADE assess-
ment of outcomes.13 Further, we only studied reviews
published in the Cochrane database of systematic reviews
so the results cannot be generalised to non-Cochrane
systematic reviews. The variables we selected for inclu-
sion in our multivariable logistic regression analysis may
not have encompassed all the factors that influenced
review authors’ interpretations about the conclusiveness
of the evidence for the use of an intervention. For
example, statistical significance may be considered as a
variable relevant in the review of authors’ interpretations
about the evidence of an effect of an intervention.
However, Fleming et al.1 identified that none of the
authors of the Cochrane and non-Cochrane reviews made
a favourable interpretation of the evidence in the absence
of a statistically significant result. Therefore, adding this
variable to our analysis would probably not increase our
understanding of factors that contribute to review
authors’ interpretations of evidence.
Conclusion
High quality of evidence, according to the GRADE
approach, was uncommon in the sample of Cochrane
systematic reviews in Anaesthesia, Critical Care and
Emergency Medicine that we analysed. We identified
that authors of many of the systematic reviews made
conclusive statements about the effects of interventions
based on very low, low andmoderate-quality evidence. In
the subgroup of conclusive reviews, only 16% had high-
quality evidence available to support the primary out-
come. These are important findings considering that
there could be negative implications for patient outcomes
from concluding that an intervention is superior, inferior
or equivalent to an alternative based on evidence that is
not high quality. Improving methodological quality of
trials in these medical disciplines would have the greatest
impact on improving the quality of evidence.
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